Position in AGEN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$311,424
+$228,788 QoQ
Shares Held
101,773
+86.0% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 103 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. AGEN ranks #277 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in AGEN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $311,424 | 101,773 | Shares | Defined | 2026-08-06 | |
| 2025-03-31 | $82,636 | 54,727 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $149,950 | 54,727 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $389,637 | 71,102 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,500,781 | 89,599 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $804,115 | 1,386,408 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,228,921 | 1,480,629 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,420,057 | 1,256,689 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,995,256 | 1,247,036 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,488,747 | 979,439 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,411,775 | 1,004,907 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,094,781 | 1,021,846 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,690,852 | 871,575 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,888,519 | 767,692 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,379,874 | 739,092 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,416,295 | 650,723 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $3,403,914 | 620,021 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,556,754 | 572,336 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,857,588 | 584,148 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,331,969 | 582,993 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,144,509 | 545,677 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,154,241 | 471,119 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||